ASIA-PACIFIC BARIATRIC SURGERY MARKET FORECAST 2024-2032

Furthermore, the competitive landscape in Japan’s obesity treatment market is marked by major players like Allergan, J&J, EnteroMedics, Medtronic, and EndoGastric Solutions, whose escalating rivalry is fueled by heightened innovation and substantial investments in research and development.

Similarly, South Korea presently exhibits a low obesity prevalence, according to the OECD, but projections indicate an impending increase. This anticipated rise is primarily attributable to shifting societal norms and behaviors. Concurrently, diabetes rates are on the uptick across all age groups, a trend linked to the burgeoning obesity epidemic, as well as sedentary lifestyles and poor dietary habits. 

Moreover, healthcare expenses in South Korea remain comparatively affordable in contrast to those in the United States and Canada. Notably, South Korea has earned recognition in Asia for its internationally accredited medical facilities, prioritizing patient well-being over financial gain. Consequently, an influx of individuals from Western nations seeking bariatric surgeries is bolstering market expansion in South Korea.

The Asia-Pacific bariatric surgery market segmentation includes device, end-user, and procedure. The device segment includes implantable devices and assisting devices. 

An implantable medical device refers to a device that is surgically placed inside the body during a medical procedure and is designed to remain post-procedure. In the context of Bariatric surgery, examples of implantable devices include the Gastric Balloon, Gastric Band, Electrical Stimulation Device, and Gastric Emptying device. These medical implants must meet specific functional requirements tailored to the conditions within the human body.

Gastric balloons are inflatable devices inserted into the stomach via endoscopy and then filled with saline solution. They occupy space within the stomach, purportedly inducing a sensation of fullness in individuals. While not a substitute for procedures like lap-band surgery or gastric bypass surgery, gastric balloons are commonly utilized for short-term weight loss interventions lasting around six months. Patients typically experience a weight loss of approximately 10% of their initial body weight within the first year following the procedure. However, a notable side effect of this method is the potential development of gastric ulcers, along with occasional reports of nausea.

Some of the leading companies in the Asia-Pacific bariatric surgery market include Allergan Inc, Olympus Corporation, Medtronic PLC, Intuitive Surgical Inc, etc.

Olympus Corporation primarily focuses on the manufacturing and sales of medical equipment, operating across four key business segments. The medical segment specializes in producing and distributing gastrointestinal endoscopes, surgical endoscopes, endoscopic treatment instruments, and ultrasonic endoscopes. Within the scientific segment, the company manufactures and sells biological microscopes, industrial microscopes, industrial endoscopes, and non-destructive inspection equipment. 

In the imaging segment, Olympus is involved in the manufacturing and sale of digital cameras and recording machines. Additionally, the Others segment encompasses the manufacture and sale of biomaterials. The company also participates in financial investment activities. It is headquartered in Shinjuku City, Tokyo, Japan.